850793-25-8

Basic information

• Product Name: 3-FLUORO-5-METHOXY-PHENOL
• Synonyms: 3-FLUORO-5-METHOXY-PHENOL
• CAS NO: 850793-25-8
• Molecular Formula: C₇H₇FO₂
• Molecular Weight: 142.128
• Mol File: 850793-25-8.mol
• Article Data: 8

Chemical Properties

• Boiling Point: 222.0±20.0 °C(Predicted)
• Appearance: /
• Density: 1.224±0.06 g/cm3(Predicted)
• Storage Temp.: under inert gas (nitrogen or Argon) at 2-8°C
• PKA: 8.59±0.10(Predicted)
• CAS DataBase Reference: 3-FLUORO-5-METHOXY-PHENOL(CAS DataBase Reference)
• NIST Chemistry Reference: 3-FLUORO-5-METHOXY-PHENOL(850793-25-8)
• EPA Substance Registry System: 3-FLUORO-5-METHOXY-PHENOL(850793-25-8)

Safety Data

• Hazardous Substances Data: 850793-25-8(Hazardous Substances Data)

Usage

General Description

3-Fluoro-5-methoxy-phenol is a chemical compound with the molecular formula C7H7FO2. It is a phenolic compound that contains a fluorine and a methoxy group attached to a benzene ring. This chemical is commonly used in organic synthesis and as a building block for the preparation of various pharmaceuticals and agrochemicals. It is also used as a reagent in chemical research and as a precursor for the synthesis of other complex organic compounds. 3-Fluoro-5-methoxy-phenol has potential applications in the field of medicinal chemistry due to its ability to modify the properties of natural and synthetic compounds, making it a valuable tool for drug development and discovery.

Upstream product

• 52189-63-6 3,5-dimethoxyfluorobenzene 
• 202925-08-4 1-chloro-3-fluoro-5-methoxybenzene 
• 609807-25-2 3-fluoro-5-methoxyphenylboronic acid 

Downstream Products

• 1307255-48-6 tert-butyl (3-endo)-3-(3-fluoro-5-methoxyphenoxy)-8-azabicyclo[3.2.1]octane-8-carboxylate 
• 920036-39-1 2-chloro-3-fluoro-5-methoxyphenol 
• 920036-40-4 4-chloro-3-fluoro-5-methoxyphenol 

Relevant articles and documents

Derivatives of m-Guaiacol, Their Preparation and Their Uses

The invention concerns derivatives of m-guaiacol, their preparation and their uses as biocides, in particular as antibacterials or disinfectants.

PROTEIN KINASE INHIBITORS

The present invention relates to a novel family of inhibitors of protein kinases. In particular, the present invention relates to inhibitors of the members of the Tec and Src protein kinase families.

Biaryl ethers as novel non-nucleoside reverse transcriptase inhibitors with improved potency against key mutant viruses

Biaryl ethers were recently reported as potent NNRTIs. Herein we disclose a detailed SAR study that led to the biaryl ether 6. This compound possessed excellent potency against WT RT and key clinically observed RT mutants and had an excellent pharmacokinetic profile in rats, dogs, and rhesus macaques. The compound also exhibited a clean safety profile in preclinical safety studies.